Cargando…
In Vivo Quantitative Imaging of Glioma Heterogeneity Employing Positron Emission Tomography
SIMPLE SUMMARY: Defining glioma heterogeneity represents a promising strategy to unravel the mechanisms behind therapy resistance and tumor recurrence. The current review provides a comprehensive overview of experimental and clinical data concerning the visualization and quantification of the tumor...
Autores principales: | Barca, Cristina, Foray, Claudia, Zinnhardt, Bastian, Winkeler, Alexandra, Herrlinger, Ulrich, Grauer, Oliver M., Jacobs, Andreas H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264799/ https://www.ncbi.nlm.nih.gov/pubmed/35804911 http://dx.doi.org/10.3390/cancers14133139 |
Ejemplares similares
-
Interrogating Glioma-Associated Microglia and Macrophage Dynamics Under CSF-1R Therapy with Multitracer In Vivo PET/MRI
por: Foray, Claudia, et al.
Publicado: (2022) -
The Colony Stimulating Factor-1 Receptor (CSF-1R)-Mediated Regulation of Microglia/Macrophages as a Target for Neurological Disorders (Glioma, Stroke)
por: Barca, Cristina, et al.
Publicado: (2021) -
Imaging temozolomide-induced changes in the myeloid glioma microenvironment
por: Foray, Claudia, et al.
Publicado: (2021) -
Quantitative accuracy of positron emission tomography/magnetic resonance and positron emission tomography/computed tomography for cervical cancer
por: Oldan, Jorge Daniel, et al.
Publicado: (2018) -
Clinical Utility of Positron Emission Tomography in Patients with Malignant Glioma
por: YANO, Hirohito, et al.
Publicado: (2017)